.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Colorcon
Johnson and Johnson
Accenture
Chinese Patent Office
US Army
Express Scripts
Dow
Citi

Generated: September 23, 2017

DrugPatentWatch Database Preview

PAMINE Drug Profile

« Back to Dashboard

Which patents cover Pamine, and when can generic versions of Pamine launch?

Pamine is a drug marketed by Fougera Pharms and is included in one NDA.

The generic ingredient in PAMINE is methscopolamine bromide. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.

Summary for Tradename: PAMINE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list27
Patent Applications: see list370
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PAMINE at DailyMed

Pharmacology for Tradename: PAMINE

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA >Approval Date TE Type RLD RS Patent No. >Patent Expiration Product Substance Delist Req. >Exclusivity Expiration
Fougera Pharms
PAMINE
methscopolamine bromide
TABLET;ORAL008848-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
PAMINE FORTE
methscopolamine bromide
TABLET;ORAL008848-002Mar 25, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Novartis
Fish and Richardson
McKesson
US Department of Justice
Mallinckrodt
Johnson and Johnson
Fuji
Queensland Health
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot